Price target
21.600.000.00%
The 5 analysts offering 1 year price forecasts for KPTI have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to KPTI in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
KPTI EPS for the last quarter is −2.77 USD despite the estimation of −4.42 USD. In the next quarter EPS is expected to reach −4.09 USD. Track more of Karyopharm Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Karyopharm Therapeutics Inc. revenue is expected to reach 38.06 M USD. Check out Karyopharm Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, KPTI price target is 21.60 USD with a max estimate of 42.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Karyopharm Therapeutics Inc. stock price chart and keep track of the current situation with KPTI news and stock market news.
We've gathered opinions of 5 analysts rating KPTI stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.